European Union

EPO Patent Publication EP2026028952A1: Synthetic Protein and Related Compositions

The European Patent Office has published patent application EP2026028952A1 concerning synthetic proteins, complexes, compositions, polynucleotides, expression vectors, and pharmaceutical compositions. The publication date is March 18, 2026, and it covers various applications including osteogenesis, cartilage proliferation, and angiogenesis promotion.

EPO Patent Publication: Bioengineered Bacteria for Biofilm Curation

The European Patent Office has published a new patent application, EP2026030202A1, concerning the use of bioengineered bacteria for curating biofilms. The publication date is March 18, 2026, and it covers various International Patent Classifications related to medical treatments and biotechnology.

EPO Patent: Cardiomyopathy Treatment With ATF4 Gene Therapy

The European Patent Office has published patent application EP2026030234A2 concerning a gene therapy for the prevention and treatment of cardiomyopathy-related diseases using ATF4. The publication date is March 18, 2026, and it covers designated states within the European Union.

EPO Patent Application EP2026030528A1 for Activated Hepatocyte Growth Factor

The European Patent Office (EPO) has published patent application EP2026030528A1 concerning activated hepatocyte growth factor. The publication date is March 18, 2026, and the inventors have not yet been designated.

NFAT1-based Therapeutics for Joint Diseases Patent

The European Patent Office has published patent application EP2026030377A1 concerning NFAT1-based therapeutics for joint diseases. The publication date is March 18, 2026, and the application includes various IPC classifications related to pharmaceutical compositions and viral vectors.

Glutamic Acid Decarboxylase Patent Publication EP2026028978A1

The European Patent Office (EPO) has published patent application EP2026028978A1 concerning Glutamic Acid Decarboxylase and its applications. The publication date is March 18, 2026. The application is classified under various International Patent Classification (IPC) codes related to biotechnology and food science.

EPO Patent Publication: HPV Vaccines (EP2026030253A1)

The European Patent Office (EPO) has published patent application EP2026030253A1 concerning Human Papillomavirus (HPV) vaccines. The publication date is March 18, 2026, and it includes IPC classifications related to vaccines and biotechnology.

Patent EP2026030180A1: Method for Optimizing Vero Cell Growth

The European Patent Office has published patent application EP2026030180A1 concerning a method for optimizing Vero cell growth. This publication relates to biotechnology and intellectual property within the pharmaceutical sector.

EPO Patent Application EP2026030647A1 for Molecules Controlling Allergic Diseases

The European Patent Office has published patent application EP2026030647A1 concerning molecules for controlling allergic diseases. The application was published on March 18, 2026, and lists various IPC classifications related to biotechnology and pharmaceuticals. The designation of inventors has not yet been filed.

EPO Patent EP2026030634A2: Sustained Transgene Expression Fusion Polypeptides

The European Patent Office has published patent application EP2026030634A2 concerning sustained transgene expression fusion polypeptides. The application details specific fusion polypeptides and their uses, with inventors not yet designated.